On Friday, Icecure Medical Ltd (NASDAQ: ICCM) opened higher 12.73% from the last session, before settling in for the closing price of $0.55. Price fluctuations for ICCM have ranged from $0.48 to $1.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 33.95%. Company’s average yearly earnings per share was noted 13.54% at the time writing. With a float of $24.12 million, this company’s outstanding shares have now reached $45.73 million.
The extent of productivity of a business whose workforce counts for 77 workers is very important to gauge. In terms of profitability, gross margin is 40.37%, operating margin of -429.36%, and the pretax margin is -407.16%.
Icecure Medical Ltd (ICCM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Icecure Medical Ltd is 51.28%, while institutional ownership is 0.73%.
Icecure Medical Ltd (ICCM) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.09 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.09) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.54% per share during the next fiscal year.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Check out the current performance indicators for Icecure Medical Ltd (ICCM). In the past quarter, the stock posted a quick ratio of 2.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
The latest stats from [Icecure Medical Ltd, ICCM] show that its last 5-days average volume of 0.58 million was superior to 0.51 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.87%. Additionally, its Average True Range was 0.04.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 29.17%, which indicates a significant decrease from 83.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.81% in the past 14 days, which was higher than the 69.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6199, while its 200-day Moving Average is $0.9584. Now, the first resistance to watch is $0.6617. This is followed by the second major resistance level at $0.7033. The third major resistance level sits at $0.7592. If the price goes on to break the first support level at $0.5642, it is likely to go to the next support level at $0.5083. The third support level lies at $0.4667 if the price breaches the second support level.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
There are currently 45,623K shares outstanding in the company with a market cap of 30.70 million. Presently, the company’s annual sales total 3,230 K according to its annual income of -14,650 K. Last quarter, the company’s sales amounted to 1,010 K and its income totaled -3,080 K.
